These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 20335053

  • 21. Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products.
    Pöbetanecker A, Cubetaler K.
    ALTEX; 1998; 15(5):71-75. PubMed ID: 11178548
    [Abstract] [Full Text] [Related]

  • 22. Screening for viral extraneous agents in live-attenuated avian vaccines by using a microbial microarray and sequencing.
    Olesen ML, Jørgensen LL, Blixenkrone-Møller M, Sandberg E, Frandsen PL, Østergaard E, Bækdahl ER, Fridholm H, Fomsgaard A, Rosenstierne MW.
    Biologicals; 2018 Jan; 51():37-45. PubMed ID: 29132963
    [Abstract] [Full Text] [Related]

  • 23. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines.
    Hess RD, Weber F, Watson K, Schmitt S.
    Vaccine; 2012 Apr 05; 30(17):2715-27. PubMed ID: 22342707
    [Abstract] [Full Text] [Related]

  • 24. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM, Seifried E.
    Transfus Clin Biol; 2006 Nov 05; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [Abstract] [Full Text] [Related]

  • 25. Tracing and control of raw materials sourcing for vaccine manufacturers.
    Faretra Peysson L.
    Biologicals; 2010 May 05; 38(3):352-3. PubMed ID: 20335052
    [Abstract] [Full Text] [Related]

  • 26. [Requirements on the production and testing of sera and vaccines].
    Bonin O.
    Fortschr Med; 1977 Jun 16; 95(23):1541-8. PubMed ID: 881153
    [Abstract] [Full Text] [Related]

  • 27. Viral safety of biological products in WHO policy.
    Grachev VP.
    Dev Biol Stand; 1991 Jun 16; 75():241-6. PubMed ID: 1794628
    [Abstract] [Full Text] [Related]

  • 28. Regulatory harmonization--a vaccine industry perspective.
    Goodrich TD.
    Dev Biol Stand; 1997 Jun 16; 90():355-61. PubMed ID: 9270864
    [Abstract] [Full Text] [Related]

  • 29. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.
    Arch Toxicol; 2008 Apr 16; 82(4):211-36. PubMed ID: 18322675
    [Abstract] [Full Text] [Related]

  • 30. New challenges in assuring vaccine quality.
    Dellepiane N, Griffiths E, Milstien JB.
    Bull World Health Organ; 2000 Apr 16; 78(2):155-62. PubMed ID: 10743279
    [Abstract] [Full Text] [Related]

  • 31. Production of poultry viral vaccines in embryonated eggs.
    Ben-Nathan D.
    Adv Biotechnol Processes; 1985 Apr 16; 5():123-47. PubMed ID: 3002406
    [Abstract] [Full Text] [Related]

  • 32. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia.
    Castle P.
    Dev Biol Stand; 1996 Apr 16; 86():21-9. PubMed ID: 8785951
    [Abstract] [Full Text] [Related]

  • 33. [Progress in the replacement of animal experiments in the quality control of clostridial vaccines].
    Cussler K, Borrmann E, Werner E.
    Dtsch Tierarztl Wochenschr; 2002 Apr 16; 109(4):172-7. PubMed ID: 11998369
    [Abstract] [Full Text] [Related]

  • 34. Viral safety in homoeopathic medicinal products.
    Schultz N, Franck-Karl G, Schilk J, Rose N.
    Pharmeur Bio Sci Notes; 2011 Jun 16; 2011(1):55-65. PubMed ID: 21619856
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I, Stacey G, Petricciani J, Sheets R, WHO Study Group on Cell Substrates.
    Biologicals; 2010 Jan 16; 38(1):162-9. PubMed ID: 19818645
    [Abstract] [Full Text] [Related]

  • 36. [Specified pathogen-free poultry flocks: the current situation].
    Rautenschlein S.
    Dtsch Tierarztl Wochenschr; 2005 Aug 16; 112(8):310-2. PubMed ID: 16218186
    [Abstract] [Full Text] [Related]

  • 37. The future European system for the free circulation of veterinary vaccines in Europe.
    Hankin R.
    Dev Biol Stand; 1992 Aug 16; 79():3-9. PubMed ID: 1286761
    [Abstract] [Full Text] [Related]

  • 38. Issues of biological assays for viral vaccines.
    Lee CK.
    Dev Biol Stand; 1996 Aug 16; 88():41-7. PubMed ID: 9119161
    [Abstract] [Full Text] [Related]

  • 39. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A.
    Dev Biol Stand; 1999 Aug 16; 101():29-35. PubMed ID: 10566772
    [Abstract] [Full Text] [Related]

  • 40. Lessons from preventive infectious disease vaccines.
    Chandler DK, Midthun K, Goldenthal KL.
    Dev Biol (Basel); 2004 Aug 16; 116():61-6; discussion 69-76. PubMed ID: 15603184
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.